Ruolin Li
-
- Cancer Treatment and Pharmacology 5
- Drug Transport and Resistance Mechanisms 3
-
- Liver Disease Diagnosis and Treatment 3
-
- DNA Repair Mechanisms 5
-
- Multiple Myeloma Research and Treatments 4
-
- Glioma Diagnosis and Treatment 3
-
- Chemotherapy-related skin toxicity 3
-
- Hormonal Regulation and Hypertension 3
- Co-authors
- Weijin LiuJia LiuHui YangXue QinQiliu PengXianjun LaoShan LiHongjie Liang
- Cited by
- Cancer ResearchNeurologyOncology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ruolin Li
46 papers receiving 788 citations
Peers
Comparison fields: 5 of 109
- Cancer Research 146
- Neurology 90
- Oncology 142
- Epidemiology 172
- Pathology and Forensic Medicine 82
Countries citing papers authored by Ruolin Li
This map shows the geographic impact of Ruolin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolin Li more than expected).
Fields of papers citing papers by Ruolin Li
This network shows the impact of papers produced by Ruolin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolin Li. The network helps show where Ruolin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruolin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2022 | 13 | |
| 7 | 2016 | 4 | |
| 8 | 2015 | 6 | |
| 9 | 2014 | 17 | |
| 10 | 2014 | 36 | |
| 11 | 2014 | 4 | |
| 12 | 2014 | 9 | |
| 13 | 2014 | 11 | |
| 14 | 2014 | 6 | |
| 15 | 2014 | 51 | |
| 16 | 2013 | 10 | |
| 17 | 2013 | 13 | |
| 18 | 2013 | 14 | |
| 19 | 2013 | 19 | |
| 20 | 2013 | 25 |
About Ruolin Li
Ruolin Li is a scholar working on Oncology, Cancer Research, Genetics, Dermatology and Hematology, having authored 53 papers that have together received 797 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Cancer Treatment and Pharmacology (5 papers), Multiple Myeloma Research and Treatments (4 papers), Glioma Diagnosis and Treatment (3 papers), Chemotherapy-related skin toxicity (3 papers), Hormonal Regulation and Hypertension (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (146 citations), Neurology (90 citations), Oncology (142 citations), Epidemiology (172 citations) and Pathology and Forensic Medicine (82 citations). Ruolin Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weijin Liu, Jia Liu, Hui Yang, Xue Qin, Qiliu Peng, Xianjun Lao, Shan Li, Hongjie Liang, Taijie Li and Zhiping Chen. Their work appears in journals such as Tumor Biology, Diagnostic Pathology, Cancer Nursing, Supportive Care in Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.